Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SOLS vs EMN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EMN Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–5 Matrix Metrics)

EMN Overall Winner 6-Pillar Tally: SOLS 2 – 4 EMN Matrix Metrics: SOLS 5 – 5 EMN

As of Nov 16, 2026, Eastman Chemical Company (EMN) is the stronger overall head-to-head candidate over Solstice Advanced Materials Inc. (SOLS) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). SOLS carries a Unified Composite Score of 34.5/100 (SELL) at $64.92 (19.3x Forward P/E, 17.2% operating margin), whereas EMN carries 43.8/100 (HOLD) at $63.49 (9.7x Forward P/E, 10.7% operating margin).

  • Technical & Structure Timing Caution: SOLS is currently in a Breakdown options structure phase (RSI 55.8); meanwhile EMN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SOLS vs EMN
SOLS US Equity
Solstice Advanced Materials Inc.
Chemicals & Allied Products
$64.92
-1.81% 1D
Market Cap $10.4B
TTM Revenue $4.17B
Forward P/E 19.3x
Beta / 30D Vol 1.66β · 67% Vol
Unified Composite Score
34.5 / 100 SELL
Tech 8.0 Fund 31.0 Flow 58.0 Mom 31.4
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 56
RSI-14: 55.8 · SMA20: $62.07 · SMA50: $60.31
EMN NYSE Head-to-Head Winner
Eastman Chemical Company
Plastic Materials, Synth Resins & Nonvulcan Elastomers
$63.49
-2.37% 1D
Market Cap $7.4B
TTM Revenue $9.05B
Forward P/E 9.7x
Beta / 30D Vol 0.79β · 28% Vol
Unified Composite Score
43.8 / 100 HOLD
Tech 41.0 Fund 52.0 Flow 60.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -4.3%) with fading momentum, RSI 43
RSI-14: 42.9 · SMA20: $65.59 · SMA50: $65.41

6-Pillar Scorecard Institutional Category Breakdown (SOLS 2 – 4 EMN)

Columns: Metric · SOLS · EMN
1. Valuation Multiples EMN
Forward P/E 19.3x 9.7x
Trailing P/E 32.4x 11.6x
PEG Ratio 0.39x 0.64x
EV / Revenue 2.9x 1.3x
2. Growth & Scale EMN
Revenue Growth (YoY) +7.9% +8.3%
Earnings Growth (YoY) +22.8% +265.0%
TTM Revenue (USD) $4.17B $9.05B
Market Cap $10.4B $7.4B
3. Profitability & Quality SOLS
Gross Margin 30.9% 20.3%
Operating Margin 17.2% 10.7%
Net Profit Margin 7.8% 6.9%
Return on Equity (ROE) 16.0% 10.3%
4. Balance Sheet & Cash Flow EMN
Cash Generation (TTM) $427M $1.50B EBITDA
Cash Flow Margin 10.2% 16.6% EBITDA Mgn
Net Cash / Leverage $1.70B Net Debt (1.55x D/E) $4.45B Net Debt (0.83x D/E)
Dividend Yield 0.34% 5.12%
5. Options & Positioning EMN
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 62.0% (22nd %ile) 29.7% (38th %ile)
Put/Call OI Skew 0.11x (Call-Skewed) 0.08x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markup ACCUMULATION · Distribution
6. R&D & Supply-Chain Moat SOLS
OpEx & R&D Intensity 13.7% of Rev ($572M) 9.6% of Rev ($869M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SOLS (5) vs EMN (5)
Institutional Metric SOLS EMN Criterion Row Edge
Market Capitalization
Scale
$10.4B $7.4B Larger Scale SOLS
Trailing P/E Ratio
Valuation
32.4x 11.6x Lower Multiple EMN
Forward P/E Ratio
Valuation
19.3x 9.7x Lower Multiple EMN
Revenue Growth (YoY)
Growth
+7.9% +8.3% Higher Growth EMN
Operating Margin (TTM)
Profitability
17.2% 10.7% Higher Margin SOLS
Net Profit Margin
Profitability
7.8% 6.9% Higher Margin SOLS
Return on Equity (ROE)
Capital Efficiency
16.0% 10.3% Higher ROE SOLS
52-Week Range Position
Momentum
49% ($40–$91) 27% ($56–$83) Stronger Trend SOLS
Beta / 30D Volatility
Risk Regime
1.66β · 67% Vol 0.79β · 28% Vol Lower Realized Risk EMN
Unified Institutional Score
Composite Signal
34.5 / 100 (SELL) 43.8 / 100 (HOLD) Higher Composite EMN
Trailing 12M Revenue (USD)
Operating Scale
$4.17B $9.05B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
30.9% 20.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.39x PEG · 2.9x EV/Rev 0.64x PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$427M ($1.70B Net Debt (1.55x D/E)) $1.50B EBITDA ($4.45B Net Debt (0.83x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SOLS +7.71 pp
SOLS: +9.57% · EMN: +1.86%
3M Horizon SOLS +21.07 pp
SOLS: +8.04% · EMN: -13.03%
6M Horizon EMN +10.4 pp
SOLS: -20.9% · EMN: -10.5%
1Y Horizon SOLS +40.73 pp
SOLS: +41.96% · EMN: +1.23%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SOLS Revenue EMN Revenue SOLS Op. Margin EMN Op. Margin Margin Leader
FY2018 N/A $10.2B N/A 10.6% EMN
FY2019 N/A $9.27B N/A 8.2% EMN
FY2020 N/A $8.47B N/A 5.6% EMN
FY2021 N/A $10.5B N/A 8.2% EMN
FY2022 N/A $10.6B N/A 7.5% EMN
FY2023 $3.65B $9.21B 17.0% 9.7% SOLS
FY2024 $3.77B $9.38B 15.8% 9.6% SOLS
FY2025 $3.89B $8.75B 6.1% 5.4% SOLS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SOLS BREAKDOWN
129d in phase · OBV ACCUMULATION
Current IV 62.0%
IV Percentile 22nd %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SOLS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EMN CONSOLIDATION
137d in phase · OBV ACCUMULATION
Current IV 29.7%
IV Percentile 38th %ile
Put/Call OI Skew 0.08x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact EMN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SOLS Moat Profile Scale & Operating Efficiency Moat
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $10.4B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 13.7% of Rev ($572M)
90D Engineering Disclosures 0 Published
EMN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $7.4B market capitalization and 10.7% operating margin.
OpEx & R&D Reinvestment 9.6% of Rev ($869M)
90D Engineering Disclosures 0 Published

Investor FAQ SOLS vs EMN Key Questions & Quantitative Answers

As of Nov 16, 2026, Eastman Chemical Company (EMN) is the stronger overall head-to-head candidate over Solstice Advanced Materials Inc. (SOLS) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). SOLS carries a Unified Composite Score of 34.5/100 (SELL) at $64.92 (19.3x Forward P/E, 17.2% operating margin), whereas EMN carries 43.8/100 (HOLD) at $63.49 (9.7x Forward P/E, 10.7% operating margin). Technical & Structure Timing Caution: SOLS is currently in a Breakdown options structure phase (RSI 55.8); meanwhile EMN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

EMN leads the Growth & Scale pillar: SOLS posts +7.9% YoY revenue growth and +22.8% YoY earnings growth on $4.17B TTM revenue (30.9% gross margin, 17.2% operating margin), compared with EMN at +8.3% YoY revenue growth and +265.0% YoY earnings growth on $9.05B TTM revenue (20.3% gross margin, 10.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SOLS cumulative revenue shifted +6.6% while EMN shifted -13.8%. In operating R&D and SG&A reinvestment, SOLS deploys 13.7% of Rev ($572M) (0 90-day corporate R&D disclosures) versus 9.6% of Rev ($869M) (0 disclosures) for EMN.

EMN screens cheaper on headline valuation multiples. SOLS trades at 19.3x Forward P/E, 32.4x Trailing P/E, 0.39x PEG, and 2.9x EV/Revenue (10.2% FCF margin), whereas EMN trades at 9.7x Forward P/E, 11.6x Trailing P/E, 0.64x PEG, and 1.3x EV/Revenue (16.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SOLS (16.0% ROE) versus EMN (10.3% ROE) capital efficiency.

In options market volatility and institutional positioning, SOLS carries 62.0% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.66β · 67% Vol realized risk). By comparison, EMN carries 29.7% implied volatility (38th %ile, Balanced (25th–60th %ile)), a 0.08x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.79β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.